Sale!

Chimerism Split Cell Analysis – B Cell CD19 Test Cost

Original price was: 2,080 د.إ.Current price is: 1,870 د.إ.

-10%

Chimerism Split Cell Analysis, specifically the B Cell CD19 Test, is an advanced diagnostic procedure available at DNA Labs UAE, designed to monitor chimerism levels in patients who have undergone hematopoietic stem cell transplantation (HSCT). This test focuses on the CD19 marker, a protein expressed on the surface of B cells, which are a type of white blood cell crucial for the immune response. By analyzing the proportion of donor and recipient cells in the patient’s blood, the B Cell CD19 Test provides valuable insights into the success of the transplantation, the risk of graft-versus-host disease (GVHD), and the patient’s overall immune reconstitution.

The test is priced at 1870 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, which is known for its cutting-edge technology and highly qualified staff. This specific analysis is vital for post-transplant care, allowing healthcare providers to tailor treatment plans effectively and monitor patients’ progress closely.

Description

CHIMERISM SPLIT CELL ANALYSIS – B CELL CD19 Test

Test Name: CHIMERISM SPLIT CELL ANALYSIS – B CELL CD19 Test

Components: Price 1870.0 AED

Sample Condition: 4 ml (2 ml min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Indicate Date of Bone Marrow Transplant; date/Lab number of Pre transplant sample of patient & donor for chimerism registered under code N057.

Report Delivery: Sample Daily by 11 am; Report 7 Working days

Method: PCR, STR / Fragment Analysis

Test type: Bone Marrow Transplantation

Doctor: Hematologist, Oncologist

Test Department:

Pre Test Information: Indicate Date of Bone Marrow Transplant; date/Lab number of Pre transplant sample of patient & donor for chimerism registered under code N057.

Test Details: Chimerism split cell analysis is a laboratory test used to determine the presence and proportion of different cell populations in an individual’s body. This test is commonly used in stem cell and organ transplant patients to assess the success of the transplantation process. In the context of B cell chimerism, the test specifically analyzes the proportion of B cells expressing the CD19 marker. CD19 is a protein found on the surface of B cells, which play a crucial role in the immune response. The chimerism split cell analysis – B cell (CD19) test involves separating the patient’s blood or bone marrow sample into individual cells. These cells are then stained with fluorescent markers specific to CD19, allowing for the identification and quantification of B cells expressing this marker. By comparing the proportion of CD19-positive B cells to the total B cell population, the test can determine the level of chimerism or the presence of different cell populations in the patient. This information is valuable in assessing the success of a stem cell or organ transplant, as well as monitoring for potential complications such as graft rejection or relapse of the underlying condition. Overall, the chimerism split cell analysis – B cell (CD19) test provides valuable insights into the immune reconstitution and engraftment process, helping clinicians make informed decisions regarding patient care and treatment.

Test Name	CHIMERISM SPLIT CELL ANALYSIS – B CELL CD19 Test
Components
Price	1870.0 AED
Sample Condition	4 ml (2 ml min.) whole blood \/ Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Indicate Date of Bone Marrow Transplant;date\/Lab number of Pre transplant sample of patient & donor for chimerism registered under code N057.
Report Delivery	Sample Daily by 11 am; Report 7 Working days
Method	PCR, STR / Fragment Analysis
Test type	Bone Marrow Transplantation
Doctor	Hematologist, Oncologist
Test Department:
Pre Test Information	Indicate Date of Bone Marrow Transplant;date/Lab number of Pre transplant sample of patient & donor for chimerism registered under code N057.
Test Details	Chimerism split cell analysis is a laboratory test used to determine the presence and proportion of different cell populations in an individual’s body. This test is commonly used in stem cell and organ transplant patients to assess the success of the transplantation process. In the context of B cell chimerism, the test specifically analyzes the proportion of B cells expressing the CD19 marker. CD19 is a protein found on the surface of B cells, which play a crucial role in the immune response. The chimerism split cell analysis – B cell (CD19) test involves separating the patient’s blood or bone marrow sample into individual cells. These cells are then stained with fluorescent markers specific to CD19, allowing for the identification and quantification of B cells expressing this marker. By comparing the proportion of CD19-positive B cells to the total B cell population, the test can determine the level of chimerism or the presence of different cell populations in the patient. This information is valuable in assessing the success of a stem cell or organ transplant, as well as monitoring for potential complications such as graft rejection or relapse of the underlying condition. Overall, the chimerism split cell analysis – B cell (CD19) test provides valuable insights into the immune reconstitution and engraftment process, helping clinicians make informed decisions regarding patient care and treatment.